SLC45A3 and prostate neoplasm: In order to analyze the potential relationship of SLC45A3 and PTEN alterations with the ERG pathway activation, prostate tumors were divided in 2 groups according to the results of ERG IHC: ERG positive (n = 103) and ERG negative (n = 117).